Practice Location

2633 NAPOLEON AVE
NEW ORLEANS, LA 70115-6340

Phone: (504) 895-2521

What does ROBERT VEITH research?

Dr. Veith studies genetic conditions that can lead to complex medical issues, such as movement disorders linked to specific gene mutations and chronic kidney disease related to diabetes. His research includes the use of advanced techniques like whole genome sequencing to diagnose genetic disorders in infants and children, which allows for early intervention and better management of their health. He also investigates treatment methods that enhance the effectiveness of dialysis access for patients with kidney failure, aiming to improve their quality of life.

Key findings

  • In a study on rapid whole genome sequencing for infants, 35% received a definitive diagnosis within about 6 days, leading to significant changes in medical management for 32% of all infants tested.
  • His analysis of patients with chronic kidney disease revealed that about 43% did not qualify for clinical trials of the drug finerenone, highlighting gaps in treatment access for type 2 diabetes patients.
  • In research on ZBTB11 variants, Dr. Veith found that 29 patients with this neurodevelopmental condition displayed complex movement disorders, with one patient improving after deep brain stimulation.
  • Whole genome sequencing diagnosed genetic disorders in 36% of revisited cases, demonstrating its value in clinical settings by altering treatment or monitoring plans.
  • Early genetic testing in critically ill infants suspected of having Kabuki syndrome showed that 10 out of 15 cases had clear genetic mutations linked to the syndrome.

Frequently asked questions

Does Dr. Veith study kidney disease?
Yes, Dr. Veith's research includes chronic kidney disease, particularly in patients with diabetes, and he focuses on improving treatment options.
What genetic disorders has Dr. Veith researched?
Dr. Veith has researched various genetic conditions, including movement disorders linked to specific gene mutations and atypical hemolytic uremic syndrome.
How does Dr. Veith's work apply to infants with genetic issues?
His studies on rapid whole genome sequencing have shown that it can significantly improve the diagnosis and management of genetic disorders in infants.
What techniques does Dr. Veith use in his research?
Dr. Veith uses advanced techniques like whole genome sequencing to diagnose genetic conditions and new interventional methods for treating kidney-related health issues.
Is Dr. Veith's work relevant to patients with movement disorders?
Yes, his research on genetic mutations associated with movement disorders directly impacts diagnosis and treatment for affected patients.

Publications in plain English

Percutaneous interventional thrombectomy of an endovascular AV-fistula, a case report.

2025

The journal of vascular access

Brzoska M, Pham Son T, Dorbath C, Veith R, Heine GH

Plain English
This study looked at a new technique for treating blood clots that can form in a specific type of dialysis access called an endovascular AV-fistula. The researchers successfully used a method called interventional thrombectomy to clear a blockage in a vein, which is important for keeping dialysis access working. This technique could help preserve the lifespan of these fistulas and reduce the need for other, more invasive procedures. Who this helps: This benefits patients with kidney failure who rely on dialysis for treatment.

PubMed

Multi-center implementation of rapid whole genome sequencing provides additional evidence of its utility in the pediatric inpatient setting.

2024

Frontiers in pediatrics

Thompson L, Larson A, Salz L, Veith R, Tsai JP +12 more

Plain English
Researchers studied the use of rapid whole genome sequencing (rWGS) in hospitals to help diagnose genetic diseases in infants. Out of 188 infants tested, 35% received a definitive diagnosis in about 6 days, with significant changes to medical management occurring for 32% of all infants and 70% of those who received a diagnosis. This research shows that rWGS can be effectively used in hospitals to improve patient care and outcomes for infants with suspected genetic issues. Who this helps: This benefits infants with suspected genetic conditions and their healthcare providers.

PubMed

Biallelic ZBTB11 Variants: A Neurodevelopmental Condition with Progressive Complex Movement Disorders.

2024

Movement disorders : official journal of the Movement Disorder Society

Ortigoza-Escobar JD, Zamani M, Dorison N, Sadeghian S, Azizimalamiri R +32 more

Plain English
This study looked at a rare genetic condition linked to changes in the ZBTB11 gene, which affects brain development and causes complex movement problems. Researchers reviewed the cases of 29 people (13 new and 16 previously documented), aged 2 to 50, and found that many had issues like abnormal movements and cataracts, with one patient showing improvement from deep brain stimulation treatment. Understanding this condition helps in identifying the symptoms and genetic factors associated with it, which is important for better diagnosis and treatment. Who this helps: This helps patients with ZBTB11-related disorders and their families, as well as doctors diagnosing and treating these conditions.

PubMed

Insights into the perinatal phenotype of Kabuki syndrome in infants identified by genome-wide sequencing.

2023

American journal of medical genetics. Part A

Wigby K, Hammer M, Tokita M, Patel P, Jones MC +17 more

Plain English
This study examined how whole-genome sequencing can help identify Kabuki syndrome in critically ill infants who were not initially suspected to have it. The researchers reviewed medical records of 15 infants and found that 10 had clear genetic mutations linked to the syndrome, while 5 had likely pathogenic ones. Many of these infants showed significant health issues, including heart problems in 14 and kidney issues in 7, and this early genetic testing led to important changes in their medical care. Who this helps: This benefits infants with undiagnosed genetic conditions and their healthcare providers.

PubMed

An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria.

2023

Cardiovascular diabetology

Bramlage P, Lanzinger S, Mühldorfer S, Milek K, Gillessen A +5 more

Plain English
This study looked at patients in Germany with type 2 diabetes and chronic kidney disease to see how many met the criteria for clinical trials testing the drug finerenone. Out of over 65,000 patients analyzed, about 43% did not qualify for the trials because they had different conditions, particularly those with normal levels of albumin in their urine. This matters because it shows that many patients who could benefit from treatments like finerenone are not being included in research or receiving recommended medications for their condition. Who this helps: Patients with chronic kidney disease and their doctors.

PubMed

Successful Application of Whole Genome Sequencing in a Medical Genetics Clinic.

2017

Journal of pediatric genetics

Bick D, Fraser PC, Gutzeit MF, Harris JM, Hambuch TM +18 more

Plain English
Researchers at the Children's Hospital of Wisconsin used whole genome sequencing (WGS) to diagnose genetic disorders in 22 patients over a three-year period. They initially found a diagnosis in 3 out of 22 patients (14%), but when they reviewed the data again, the diagnosis rate increased to 8 out of 22 (36%). In most cases where a diagnosis was made, it led to changes in treatment or monitoring, highlighting the importance of genetic testing for effective patient care. Who this helps: This helps patients with suspected genetic disorders and their doctors by providing better diagnosis and treatment options.

PubMed

Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome.

2015

Clinical journal of the American Society of Nephrology : CJASN

Mele C, Lemaire M, Iatropoulos P, Piras R, Bresin E +13 more

Plain English
This study looked at a genetic mutation linked to a rare condition called atypical hemolytic uremic syndrome (aHUS), which often causes severe kidney problems in infants. Researchers found a new mutation in a gene called DGKE in two unrelated families; one family showed the mutation alongside another mutation, and both had similar symptoms like kidney issues and relapsing episodes. This discovery is important because it highlights that noncoding regions of genes, which are often ignored in genetic testing, can hold clues for diagnosing rare genetic disorders. Who this helps: This helps patients with genetically unexplained aHUS and their doctors by providing potential avenues for diagnosis and treatment.

PubMed

In the absence of evidentiary harm, existing societal norms regarding parental authority should prevail.

2014

The American journal of bioethics : AJOB

Strong KA, Derse AR, Dimmock DP, Zusevics KL, Jeruzal J +9 more

PubMed

Views of primary care providers regarding the return of genome sequencing incidental findings.

2014

Clinical genetics

Strong KA, Zusevics KL, Bick D, Veith R

Plain English
This study looked at what primary care providers think about sharing unexpected results from genome sequencing with their patients. Out of 258 surveyed, many doctors who were open to using sequencing did not always want to know about these unexpected results, even if there were ways to act on them. This is important because it highlights that doctors, who play a key role in deciding how this technology is used, may differ in their views on sharing certain findings with patients. Who this helps: This helps patients and their doctors by informing conversations about genome sequencing results.

PubMed

Views of nonmedical, health system professionals regarding the return of whole genome sequencing incidental findings.

2014

WMJ : official publication of the State Medical Society of Wisconsin

Strong KA, Zusevics KL, Bick DP, Veith R

Plain English
This study looked at the views of medical coders (non-doctors) on receiving incidental findings from whole genome sequencing, which can include unexpected health information. Almost all of the 97 participants, mostly experienced women, wanted to receive all types of results for themselves and their children, showing a significant interest compared to genetic professionals. This matters because understanding these preferences can help shape guidelines on what genetic information should be shared in clinical settings. Who this helps: Patients and their families who undergo genome sequencing.

PubMed

Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study.

2013

Clinical genetics

Lemke AA, Bick D, Dimmock D, Simpson P, Veith R

Plain English
This study surveyed 279 clinical genetics professionals to understand their views on genome sequencing and the management of unexpected results findings. Most respondents—96% for themselves and 99% for their children—expressed a desire to know about useful incidental findings, with high support for sharing these results regardless of whether they relate to adults or children. This research highlights the importance of understanding how healthcare providers think about sharing genetic information, which can help shape future practices in genetic testing. Who this helps: This benefits patients and their families by ensuring they receive important health information.

PubMed

A rare presentation of neonatal stridor.

2012

Clinical pediatrics

Amos L, Quintero D, Veith R, Trapane P, Beste D +1 more

PubMed

Pancreatic insufficiency in Toriello-Carey syndrome: report of a second patient.

2012

American journal of medical genetics. Part A

El-Chammas KI, Venkatasubramani N, Veith R, Sekhri N, Rhead W +2 more

Plain English
This study focused on Toriello-Carey syndrome, which causes various birth defects, particularly looking at how it can lead to pancreatic insufficiency. The researchers identified a second patient with this syndrome who had difficulty with digestion, confirmed through specific tests that showed low enzyme levels. This finding is important as it helps healthcare providers better diagnose and manage digestive issues in patients with Toriello-Carey syndrome. Who this helps: This helps doctors and healthcare providers who treat patients with Toriello-Carey syndrome.

PubMed

Distant positioning of proteasomal proteolysis relative to actively transcribed genes.

2011

Nucleic acids research

Scharf A, Grozdanov PN, Veith R, Kubitscheck U, Meier UT +1 more

Plain English
This study examined how proteins are broken down in cells, particularly in relation to active genes. Researchers found that proteasomes, which are responsible for destroying unwanted proteins, are usually located far away from genes that are being expressed in the embryos of a tiny roundworm called C. elegans. This matters because it shows that the way proteins are degraded is organized in space and changes depending on whether a gene is active or not, which could help us understand how genes respond to different environmental conditions. Who this helps: This helps researchers studying gene regulation and the mechanisms of protein breakdown in cells.

PubMed

Activated STAT1 transcription factors conduct distinct saltatory movements in the cell nucleus.

2011

Biophysical journal

Speil J, Baumgart E, Siebrasse JP, Veith R, Vinkemeier U +1 more

Plain English
This study looked at how a protein called STAT1 behaves when it gets activated inside cells. Researchers discovered that before activation, STAT1 moves quickly and randomly. After activation, its movement slows down by about 2.5 times in the cytoplasm, but in the nucleus, it can actively visit target areas where it influences gene activity within about 2 seconds. Understanding these movements helps scientists learn more about how genes are regulated, which is important for improving treatments in various diseases. Who this helps: This helps doctors and researchers working on treatments for diseases related to gene expression.

PubMed

Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency.

2010

European journal of human genetics : EJHG

Renard M, Holm T, Veith R, Callewaert BL, Adès LC +12 more

Plain English
This study looked at a group of patients with a condition called cutis laxa, particularly focusing on changes in their blood vessels related to a protein called fibulin-4. They found that while the FBLN4 gene was not mutated in 17 patients, three mutations were discovered in a second group of 22 patients, leading to serious issues like aortic aneurysms and narrowed arteries. The findings highlight how fibulin-4 is crucial for healthy blood vessels and suggest that changes in a specific signaling pathway (TGFbeta) play a role in the health problems seen in these patients. Who this helps: This helps patients with fibulin-4 related conditions and their doctors.

PubMed

Light sheet microscopy for single molecule tracking in living tissue.

2010

PloS one

Ritter JG, Veith R, Veenendaal A, Siebrasse JP, Kubitscheck U

Plain English
This research developed a new microscopy technique that allows scientists to observe individual molecules in living tissues with greater clarity and speed. Using this method, researchers successfully tracked small and large molecules in solutions and living cells, even deep within tissues, with a high level of detail. Specifically, they were able to visualize the movement of molecules in cells from Chironomus tentans larvae, reaching depths of up to 200 micrometers, which enhances our understanding of molecular behavior in biological systems. Who this helps: This benefits researchers in biology and medicine by providing a powerful tool for studying cellular and molecular processes.

PubMed

Balbiani ring mRNPs diffuse through and bind to clusters of large intranuclear molecular structures.

2010

Biophysical journal

Veith R, Sorkalla T, Baumgart E, Anzt J, Häberlein H +3 more

Plain English
This study looked at how messenger ribonucleoprotein particles (mRNPs) move within the nuclei of salivary gland cells. Researchers found that these mRNPs have two main mobility levels, moving at rates of 0.3 and 0.73 square micrometers per second, influenced by large molecular structures in the nucleus that slow them down. Understanding these movements helps clarify how genes are expressed, which is important for many biological processes. Who this helps: This helps researchers understand gene expression better, which can benefit patients with genetic disorders.

PubMed

Comparing perceived burden for Korean and American informal caregivers of stroke survivors.

2009

Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses

Choi-Kwon S, Mitchell PH, Veith R, Teri L, Buzaitis A +6 more

Plain English
This study looked at how caregivers of stroke survivors in Korea and the United States feel about their caregiving responsibilities. Researchers found that Korean caregivers reported feeling more burdened than American caregivers, with higher levels of dissatisfaction in their relationships with the stroke survivors they care for. Key factors affecting this burden included depression in both the caregivers and patients, as well as the amount of social support they received. Who this helps: This information benefits caregivers and healthcare providers by highlighting the need for culturally sensitive support for stroke survivors and their families.

PubMed

Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer.

2009

Anticancer research

Simmons C, Amir E, Dranitsaris G, Clemons M, Wong B +2 more

Plain English
This study looked at the effects of long-term use of bisphosphonates, a type of medication, on calcium levels and vitamin D in patients with metastatic breast cancer that has spread to the bones. Researchers found that while the overall calcium levels were normal, the hormone parathyroid hormone (PTH) was significantly higher in these patients (5.7 pmol/L compared to 4.8 pmol/L in healthy controls). Additionally, 62% of the patients had low vitamin D levels, even though they were taking supplements. Who this helps: This information benefits patients with metastatic breast cancer and their doctors by highlighting the need for better management of calcium and vitamin D levels during long-term bisphosphonate therapy.

PubMed

Living well with stroke: design and methods for a randomized controlled trial of a psychosocial behavioral intervention for poststroke depression.

2008

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Mitchell PH, Teri L, Veith R, Buzaitis A, Tirschwell D +4 more

Plain English
This study looked at how a short behavioral program combined with antidepressant treatment can help people who are depressed after having a stroke. They found that among 101 stroke survivors, this new intervention improved mood and function over time compared to just usual care with antidepressants. This matters because it could help patients have a better quality of life and recover more fully after a stroke. Who this helps: Stroke survivors dealing with depression.

PubMed

High-contrast single-particle tracking by selective focal plane illumination microscopy.

2008

Optics express

Ritter JG, Veith R, Siebrasse JP, Kubitscheck U

Plain English
This study developed a special type of microscope that reduces background noise when looking at tiny molecules in biological samples. The new tool can focus on small areas and clearly show details, achieving a thickness of just 1.7 micrometers at a specific light wavelength. This is important because it allows scientists to better observe and track how molecules move and interact in living systems, which can lead to new insights in biology and medicine. Who this helps: This benefits researchers studying cellular processes and developing new treatments.

PubMed

Association of serotonin transporter gene polymorphisms with poststroke depression.

2008

Archives of general psychiatry

Kohen R, Cain KC, Mitchell PH, Becker K, Buzaitis A +5 more

Plain English
This study looked at how certain genetic variations in the serotonin transporter gene (SERT) affect the likelihood of experiencing depression after a stroke. It found that stroke survivors with specific gene variations, like the 5-HTTLPR s/s genotype and the STin2 9/12 or 12/12 genotypes, are 3 to 4 times more likely to develop post-stroke depression compared to those with other gene types. Understanding these genetic connections is important because it can help identify stroke survivors who are at higher risk for depression, allowing for better monitoring and treatment. Who this helps: Patients who have had a stroke and may be at risk for depression.

PubMed

Discontinuous movement of mRNP particles in nucleoplasmic regions devoid of chromatin.

2008

Proceedings of the National Academy of Sciences of the United States of America

Siebrasse JP, Veith R, Dobay A, Leonhardt H, Daneholt B +1 more

Plain English
This study looked at how a specific type of messenger ribonucleoprotein particle, called BR2 mRNP, moves within the nucleus of salivary gland cells in a type of midge. Researchers found that these particles move randomly but do so in a stop-and-start manner, slowing down between movements by as much as 250 times. Understanding this movement is important because it sheds light on how genetic material is processed and transported in cells, which can impact how genes are expressed. Who this helps: This helps researchers studying gene expression and cellular processes.

PubMed

Rx: Recruitment for practical nursing students. Take more students and save money!

2006

The Journal of practical nursing

Fox C, Veith R

PubMed

Zyoptix: the Bausch & Lomb wavefront platform.

2004

Ophthalmology clinics of North America

Gulani AC, Probst L, Cox I, Veith R

Plain English
The study focused on the Zyoptix system from Bausch & Lomb, which customizes eye surgery to reshape the cornea. The results showed that this method significantly improved vision clarity and the ability to see in low contrast conditions compared to traditional laser surgery. This matters because better vision can greatly enhance daily life and reduce dependence on glasses or contact lenses. Who this helps: Patients needing vision correction.

PubMed

Vitamin D intake and incidence of multiple sclerosis.

2004

Neurology

Ebers GC, Sadovnick AD, Veith R

PubMed

Inverse response of leukocyte heat shock proteins and DNA damage to exercise and heat.

2003

Free radical research

Fehrenbach E, Veith R, Schmid M, Dickhuth HH, Northoff H +1 more

Plain English
This study looked at how exercising in high heat affects certain protective proteins and DNA damage in white blood cells. Researchers found that when athletes ran in hotter conditions (28°C), their bodies increased the production of protective proteins called heat shock proteins (HSP) to help reduce DNA damage, showing that DNA damage was less in high heat compared to cooler conditions (18°C). This is important because it suggests that heat exposure might actually help cells cope with the stress from exercise by protecting their DNA. Who this helps: This helps athletes and trainers by informing them about how heat can influence exercise and cellular health.

PubMed

Changes of HSP72-expression in leukocytes are associated with adaptation to exercise under conditions of high environmental temperature.

2001

Journal of leukocyte biology

Fehrenbach E, Niess AM, Veith R, Dickhuth HH, Northoff H

Plain English
This study looked at how a protein called HSP72 in white blood cells reacts to endurance exercise and heat in athletes who are not used to exercising in hot conditions. The researchers found that athletes running in the heat showed higher levels of HSP72 right after a workout and over the following days, suggesting that their bodies adapted better to the heat. Specifically, after their second run in the heat, their HSP72 levels dropped quicker, indicating improved heat adaptation. Who this helps: This findings benefit athletes training in hot weather.

PubMed

Prevention of breast cancer in high-risk women.

1999

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society

Kardinal CG, Veith R

Plain English
This study looked at how effective the drug tamoxifen is at preventing breast cancer in women who are at high risk of developing the disease. The trial involved 13,388 women and showed that taking tamoxifen for five years reduced the chance of getting invasive breast cancer by 49% and noninvasive breast cancer by 50%. These findings are important because they provide a powerful option for reducing breast cancer risk in vulnerable populations. Who this helps: This benefits high-risk women who want to lower their chances of developing breast cancer.

PubMed

Cardiovascular and catecholamine response to orthostasis in panic and obsessive-compulsive disorder and normal controls: effects of anxiety and novelty.

1997

Depression and anxiety

Roy-Byrne P, Cowley DS, Stein MB, Wingerson D, Veith R

Plain English
This study looked at how people with panic disorder, obsessive-compulsive disorder (OCD), and those without either condition responded to changes in body position (like standing up) regarding their heart function and stress hormone levels. It found that while all groups experienced similar increases in heart rate and hormone levels, those with panic disorder had higher norepinephrine levels overall and showed less of a change in diastolic blood pressure on the first day of the test. These results suggest that people with panic disorder do not consistently respond differently to these physical tests compared to others, helping refine our understanding of their conditions. Who this helps: This research benefits mental health doctors and their patients by providing clearer insights into panic disorder responses.

PubMed

Changing cancer outcome: the role of LSUMC Minority-Based Clinical Community Oncology Program.

1997

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society

Hayden J, Veith R, Thomas SM, Austin JP, Moore T

Plain English
This study looked at a program created by Louisiana State University Medical Center to improve cancer treatment for minority and low-income patients in South Louisiana. The program has successfully connected these patients with advanced cancer care options and clinical trials, helping an underserved community gain access to better health services. Due to its success, the program is seeking continued funding for another five years to keep supporting these crucial initiatives. Who this helps: This benefits minority and low-income cancer patients who need better access to treatment and clinical trials.

PubMed

RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study.

1997

Blood

Adams-Graves P, Kedar A, Koshy M, Steinberg M, Veith R +5 more

Plain English
This study looked at a treatment called RheothRx for managing painful episodes in patients with sickle cell disease. In a trial involving 50 patients, those treated with RheothRx experienced a 16% to 45% decrease in how long their pain lasted, a 1- to 2-day shorter hospital stay, and reduced pain intensity after 72 hours compared to those who received a placebo. This treatment matters because it offers a potential way to lessen pain and improve the quality of life for people suffering from severe episodes. Who this helps: Patients with sickle cell disease experiencing painful episodes.

PubMed

NMR observation of diffusion barriers for lithium adsorbed on Ru(001).

1996

Physical review letters

Ebinger HD, Jänsch HJ, Polenz C, Polivka B, Preyss W +3 more

PubMed

Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.

1995

Leukemia

Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M +3 more

Plain English
This study focused on the use of Carboplatin, a chemotherapy drug, to treat adults with relapsed or refractory acute myeloid leukemia (AML). Out of 45 patients, only 3 (or 7%) achieved complete remission, and there were serious side effects, with 12 patients dying from complications related to the treatment. These results show that Carboplatin is not an effective option for these patients. Who this helps: This research helps doctors make better treatment decisions for patients with difficult-to-treat AML.

PubMed

Coverage dependence of the local density of states at the Fermi energy: Li adsorbed on Ru(001).

1995

Physical review letters

Jänsch HJ, Arnolds H, Ebinger HD, Polenz C, Polivka B +5 more

PubMed

Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation, and plasma catecholamines.

1993

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Roy-Byrne P, Fleishaker J, Arnett C, Dubach M, Stewart J +3 more

Plain English
Researchers examined how the medication alprazolam affects blood flow in the brain, memory, sedation, and certain hormones in healthy men, both right after taking it and after a week of daily use. They found that a single dose of alprazolam decreased brain blood flow by 25% to 30%, reduced memory performance, and lowered levels of the stress hormones epinephrine and norepinephrine. However, after a week of regular use, the body became tolerant to these effects, meaning they were less pronounced over time. Who this helps: This study benefits patients who use alprazolam for anxiety or insomnia, as it highlights how their bodies may adapt to the medication over time.

PubMed

Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment.

1993

Brain research

Szot P, Ashliegh EA, Kohen R, Petrie E, Dorsa DM +1 more

Plain English
This study looked at how a drug called desipramine affects a specific part of the brain called the locus coeruleus, focusing on the levels of a messenger molecule, known as norepinephrine transporter (NET) mRNA. Researchers found that both short-term (2 days) and long-term (4 weeks) treatment with desipramine led to a significant increase in NET mRNA in this brain region, showing that the drug appears to boost the production of this transporter. Understanding these changes is important because it helps shed light on how antidepressants work, potentially leading to better treatments for depression. Who this helps: This research benefits patients dealing with depression and their doctors.

PubMed

Triple arthrodesis using internal fixation in treatment of adult foot disorders.

1993

Clinical orthopaedics and related research

Sangeorzan BJ, Smith D, Veith R, Hansen ST

Plain English
This study looked at how well a surgical procedure called triple arthrodesis works for adults with foot problems. After an average of nearly five years post-surgery, 34 out of 44 fused feet had good results, with most patients able to walk painlessly on flat surfaces and only experiencing mild pain during more intense activities. This matters because it shows that when done correctly, this surgery can significantly improve foot function and reduce pain for adults with serious foot disorders. Who this helps: This helps patients with disabling foot conditions.

PubMed

Liver releases galanin during sympathetic nerve stimulation.

1992

The American journal of physiology

Kowalyk S, Veith R, Boyle M, Taborsky GJ

Plain English
This study looked at how the liver and gut release a substance called galanin when the body is under stress, like during sympathetic nerve activation. Researchers found that while the gut released a small amount of galanin (about 4.8 pmol/min), the liver released much more—around 27.9 pmol/min during nerve stimulation and even more during stimulation specific to the liver (53.3 pmol/min). This is important because it reveals that the liver plays a significant role in releasing galanin under stress, which could be crucial for understanding how the body reacts in high-stress situations. Who this helps: This helps doctors and researchers better understand liver functions in stress responses.

PubMed

Factors influencing serial measurements of cardiac volumes by count-based methods: effects of elevated catecholamines, position, and exercise on technetium-99m-blood radioactivity concentration.

1992

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Levy WC, Cerqueira MD, Veith R, Stratton JR

Plain English
This study looked at how different factors like elevated adrenaline, body position, and exercise affect the measurement of blood radioactivity, which is crucial for determining heart volume. Researchers found that a small dose of adrenaline increased blood radioactivity by 4.1%, sitting increased it by 12.3%, and exercising while lying down raised it by 11%. Younger individuals showed a bigger increase from exercise compared to older participants, suggesting that body position and activity level can significantly impact heart measurements. Who this helps: This helps doctors and researchers accurately assess heart health in patients by understanding how these factors affect measurements.

PubMed

Sucrose storage in cell suspension cultures of Saccharum sp. (sugarcane) is regulated by a cycle of synthesis and degradation.

1991

Planta

Wendler R, Veith R, Dancer J, Stitt M, Komor E

Plain English
This study looked at how sugarcane cells store and break down sucrose, a type of sugar. Researchers found that sucrose starts to build up after about five days when nitrogen runs low, and they discovered that this storage is controlled by a process where sucrose is both made and broken down at the same time. Specifically, the activity of an enzyme that helps create sucrose doubles when the cells are storing it, showing that managing sugar levels in the cells is more complex than just making it. Who this helps: This benefits researchers and farmers looking to optimize sugarcane production.

PubMed

Induction of fetal hemoglobin by cell-cycle-specific drugs and recombinant erythropoietin.

1990

The American journal of pediatric hematology/oncology

Stamatoyannopoulos G, Veith R, al-Khatti A, Papayannopoulou T

Plain English
This study explored how certain drugs can increase levels of fetal hemoglobin, a type of hemoglobin found in newborns, in adults. Researchers found that using high doses of erythropoietin, along with a drug called hydroxyurea, significantly raised the number of fetal hemoglobin-producing cells in the blood. This is important because increasing fetal hemoglobin can help treat blood disorders like sickle cell disease and thalassemia by improving how blood carries oxygen. Who this helps: Patients with sickle cell disease and thalassemia.

PubMed

Methotrexate stimulates fetal hemoglobin production in anemic baboons.

1989

Progress in clinical and biological research

Veith R, Dautenhahn AG, Roth RC

PubMed

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression.

1989

The American journal of psychiatry

Reifler BV, Teri L, Raskind M, Veith R, Barnes R +2 more

Plain English
This study looked at 61 people with Alzheimer's disease, some of whom also had depression. They found that after 8 weeks, those treated with the drug imipramine saw a noticeable improvement in their depression symptoms, whether they had depression or not. This shows that treating depression can be effective in Alzheimer’s patients, which is important because it can help improve their overall quality of life. Who this helps: This helps patients with Alzheimer's, especially those also dealing with depression.

PubMed

Clonal development of the acute leukemias.

1989

Bone marrow transplantation

Fialkow PJ, Raskind WR, Singer JW, Dow LW, Najfeld V +1 more

PubMed

Preliminary evidence of benzodiazepine subsensitivity in panic disorder.

1989

Biological psychiatry

Roy-Byrne PP, Lewis N, Villacres E, Diem H, Greenblatt DJ +2 more

PubMed

On the induction of fetal hemoglobin in the adult; stress erythropoiesis, cell cycle-specific drugs, and recombinant erythropoietin.

1987

Progress in clinical and biological research

Stamatoyannopoulos G, Veith R, Al-Khatti A, Fritsch EF, Goldwasser E +1 more

PubMed

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia.

1987

The New England journal of medicine

Fialkow PJ, Singer JW, Raskind WH, Adamson JW, Jacobson RJ +4 more

Plain English
This study looked at 27 patients with acute nonlymphocytic leukemia to understand how the disease develops and whether patients really go into remission. Researchers found that in most cases, the leukemia came from a single cell, with only 8 out of 13 patients showing signs of normal blood cell production during remission. This research shows that leukemia can behave differently in different patients, which is important for developing targeted treatments. Who this helps: This helps patients with acute nonlymphocytic leukemia and their doctors.

PubMed

Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.

1985

The New England journal of medicine

Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G

Plain English
This study looked at how two medications, cytarabine and hydroxyurea, can boost the production of fetal hemoglobin in patients with sickle-cell anemia. The researchers found that higher doses of these drugs resulted in a higher number of F-cells, which are beneficial for managing the disease; for example, treatments increased F-cell production significantly and improved blood levels. This is important because boosting fetal hemoglobin can help reduce the complications of sickle-cell anemia and improve patient outcomes. Who this helps: Patients with sickle-cell anemia.

PubMed

Frequent Co-Authors

Ulrich Kubitscheck David Bick Kimberly A Strong Jan Peter Siebrasse Pamela H Mitchell Linda Teri Ann Buzaitis Kevin C Cain David Tirschwell G Stamatoyannopoulos

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.